Table 3.

Flow-cytometric data in patients with RA after anti-TNFα treatment

Before treatment
(n = 10)
After treatment
(n = 10)
P
BMMC fraction    
 % CD34+cells 1.21 ± 0.403-150 2.03 ± 0.73 .003 
 (1.20, 0.60-1.80) (2.00, 0.70-3.50)  
 % CD34+/CD38+cells 0.86 ± 0.39 1.72 ± 0.66 .004 
 (0.86, 0.20-1.40) (1.75, 0.60-3.20)  
 % CD34+/CD38cells 0.34 ± 0.18 0.31 ± 0.24 .696 
 (0.32, 0.10-0.70) (0.25, 0.10-0.90)  
CD34+ cell fraction    
 % Fas+ cells 16.20 ± 7.26 10.87 ± 6.25 .029 
 (15.48, 5.60-25.70) (10.15, 2.60-19.60)  
 % 7AADdimcells 16.09 ± 10.57 8.31 ± 5.65 .016 
 (13.85, 3.30-32.07) (6.30, 2.80-18.60)  
CD34+/Fas+ cell fraction    
 % 7AADdimcells 43.94 ± 21.07 24.84 ± 16.87 .009 
 (39.87, 12.30-73.70) (19.95, 8.70-58.10)  
CD34+/Fas cell fraction    
 % 7AADdimcells 7.69 ± 6.15 7.79 ± 5.30 .972 
 (6.40, 2.90-24.08) (7.25, 2.30, 17.0)  
Before treatment
(n = 10)
After treatment
(n = 10)
P
BMMC fraction    
 % CD34+cells 1.21 ± 0.403-150 2.03 ± 0.73 .003 
 (1.20, 0.60-1.80) (2.00, 0.70-3.50)  
 % CD34+/CD38+cells 0.86 ± 0.39 1.72 ± 0.66 .004 
 (0.86, 0.20-1.40) (1.75, 0.60-3.20)  
 % CD34+/CD38cells 0.34 ± 0.18 0.31 ± 0.24 .696 
 (0.32, 0.10-0.70) (0.25, 0.10-0.90)  
CD34+ cell fraction    
 % Fas+ cells 16.20 ± 7.26 10.87 ± 6.25 .029 
 (15.48, 5.60-25.70) (10.15, 2.60-19.60)  
 % 7AADdimcells 16.09 ± 10.57 8.31 ± 5.65 .016 
 (13.85, 3.30-32.07) (6.30, 2.80-18.60)  
CD34+/Fas+ cell fraction    
 % 7AADdimcells 43.94 ± 21.07 24.84 ± 16.87 .009 
 (39.87, 12.30-73.70) (19.95, 8.70-58.10)  
CD34+/Fas cell fraction    
 % 7AADdimcells 7.69 ± 6.15 7.79 ± 5.30 .972 
 (6.40, 2.90-24.08) (7.25, 2.30, 17.0)  

Median and range values are indicated in parentheses. Statistical analysis was performed using the Student t test for paired samples. P value ≤ .05 was considered statistically significant.

BMMC indicates bone marrow mononuclear cells.

F3-150

All values are expressed as means ± SD.

Close Modal

or Create an Account

Close Modal
Close Modal